Quillivant XR

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers, 20 USDMF, 16 CEP/COS, 1 JDMF, 6 EU WC, 8 KDMF, 21 NDC API, 18 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

DOSSIERs // Finished Dosage Forms

527 Dossiers, 262 FDA Orange Book, 163 Europe, 49 Canada, 26 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG, TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 18MG, TABLET, EXTENDED RELEASE;ORAL - 27MG, TABLET, EXTENDED RELEASE;ORAL - 36MG, TABLET, EXTENDED RELEASE;ORAL - 54MG, CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, CAPSULE, EXTENDED RELEASE;ORAL - 60MG, SOLUTION;ORAL - 10MG/5ML, SOLUTION;ORAL - 5MG/5ML, TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 39 Kerry, 38 BASF, 36 Roquette, 20 Microlex e.U, 20 Corel Pharma Chem, 19 SPI Pharma, 15 Ideal Cures Pvt Ltd, 13 Gangwal Healthcare, 12 Actylis, 11 Sigachi Industries, 11 Gangwal Chemicals, 9 Nanjing Well Pharmaceutical, 9 Seppic, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Rochem International Inc, 6 The Dow Chemical Company, 6 DFE Pharma, 6 Lonza Capsugel, 5 Kima Chemical, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Prachin Chemical, 4 Pharmatrans-Sanaq, 4 Ingredion Pharma Solutions, 4 ACG Worldwide, 4 DKSH, 3 Vertellus, 3 Evonik, 3 Vasa Pharmachem, 2 Seqens, 2 Finar, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Hayashibara, 2 Pharm-RX Chemical, 2 Pfanstiehl, 2 Qualicaps, 2 Nomisma Healthcare, 2 Alcedo Pharmachem, 2 Zhejiang Huakang Pharmaceutical, 1 Ulanqab Kema New Material, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Bioplus Life Sciences, 1 Jai Radhe Sales, 1 NEWEDGE Overseas, 1 Nanjing Bold Chemical, 1 Chynops Pharma, 1 Minakem, 1 Boai NKY Pharmaceuticals Ltd

EXCIPIENTS BY APPLICATIONS

97 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 54 Controlled & Modified Release, 42 Direct Compression, 41 Thickeners and Stabilizers, 36 Taste Masking, 30 Solubilizers, 29 Film Formers & Plasticizers, 29 Granulation, 28 Disintegrants & Superdisintegrants, 26 Lubricants & Glidants, 23 Parenteral, 22 Chewable & Orodispersible Aids, 21 Topical, 15 Co-Processed Excipients, 9 Empty Capsules, 8 API Stability Enhancers, 6 Emulsifying Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

101 US Medicaid Prescriptions, 81 Finished Drug Prices

MARKET PLACE

10 APIs, 2 DOSSIERS // FDF, 1 CONTRACT SERVICES

PATENTS

186 US Patents, 6 US Exclusivities, 27 Health Canada Patents

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 2 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 69 News

List of USP reference standards related to Quillivant XR

Quillivant XR

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

36 Suppliers

20 USDMF

16 CEP/COS

1 JDMF

6 EU WC

8 KDMF

21 NDC API

18 Listed Suppliers

DEVELOPMENTS

11 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

DOSSIERs // Finished Dosage Forms

527 Dossiers

262 FDA Orange Book

163 Europe

49 Canada

26 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET, EXTENDED RELEASE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION, EXTENDED RELEASE;ORAL - 5MG/ML

TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 20MG

TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 30MG

TABLET, EXTENDED RELEASE, CHEWABLE;ORAL - 40MG

TABLET, EXTENDED RELEASE;ORAL - 18MG

TABLET, EXTENDED RELEASE;ORAL - 27MG

TABLET, EXTENDED RELEASE;ORAL - 36MG

TABLET, EXTENDED RELEASE;ORAL - 54MG

CAPSULE, EXTENDED RELEASE;ORAL - 10MG

CAPSULE, EXTENDED RELEASE;ORAL - 20MG

CAPSULE, EXTENDED RELEASE;ORAL - 30MG

CAPSULE, EXTENDED RELEASE;ORAL - 40MG

CAPSULE, EXTENDED RELEASE;ORAL - 50MG

CAPSULE, EXTENDED RELEASE;ORAL - 60MG

SOLUTION;ORAL - 10MG/5ML

SOLUTION;ORAL - 5MG/5ML

TABLET, CHEWABLE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, CHEWABLE;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, CHEWABLE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

39 Kerry

38 BASF

36 Roquette

20 Microlex e.U

20 Corel Pharma Chem

19 SPI Pharma

15 Ideal Cures Pvt Ltd

13 Gangwal Healthcare

12 Actylis

11 Sigachi Industries

11 Gangwal Chemicals

9 Nanjing Well Pharmaceutical

9 Seppic

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Rochem International Inc

6 The Dow Chemical Company

6 DFE Pharma

6 Lonza Capsugel

5 Kima Chemical

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Prachin Chemical

4 Pharmatrans-Sanaq

4 Ingredion Pharma Solutions

4 ACG Worldwide

4 DKSH

3 Vertellus

3 Evonik

3 Vasa Pharmachem

TABLET, EXTENDED RELEASE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, CHEWABLE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, CHEWABLE;ORAL - 2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, CHEWABLE;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons